Stocks and Investing
Stocks and Investing
Tue, January 31, 2023
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
[ Tue, Jan 31st 2023
] - WOPRAI
Chris Shibutani Maintained (BNTX) at Hold with Decreased Target to $156 on, Jan 31st, 2023
Chris Shibutani of Goldman Sachs, Maintained "BioNTech SE" (BNTX) at Hold with Decreased Target from $177 to $156 on, Jan 31st, 2023.
Chris has made no other calls on BNTX in the last 4 months.
There are 4 other peers that have a rating on BNTX. Out of the 4 peers that are also analyzing BNTX, 3 agree with Chris's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $216 on, Tuesday, January 24th, 2023
- Emmanuel Papadakis of "Deutsche Bank" Maintained at Hold with Decreased Target to $160 on, Friday, November 11th, 2022
- Jessica Fye of "JP Morgan" Maintained at Hold with Decreased Target to $132 on, Monday, October 24th, 2022
This is the rating of the analyst that currently disagrees with Chris
- Tazeen Ahmad of "B of A Securities" Upgraded from Hold to Strong Buy and Held Target at $239 on, Thursday, December 15th, 2022
Contributing Sources